OncoMed Pharmaceuticals

NCT00744562

A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

NCT01189929

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

NCT01189942

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

NCT01189968

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

NCT01277146

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

NCT01345201

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

NCT01608867

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

NCT01703572

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

NCT01778439

A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors

NCT01952249

A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

NCT01957007

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

NCT01973309

A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

NCT02005315

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

NCT02050178

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

NCT02069145

Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer

NCT02092363

Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer

NCT02298387

A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors

NCT02482441

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

NCT02722954

A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors

NCT03030287

A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

NCT03035253

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

NCT03031691

A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer

NCT03119428

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03295942

A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors